SUVENPHAR (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE has received clarifications from Raymond Ltd, Sanstar Ltd, and Suven Life Sciences Ltd regarding significant price/volume movements. … | |||||||||||||||
BSE has received clarifications from Raymond Ltd, Sanstar Ltd, and Suven Life Sciences Ltd regarding significant price/volume movements. Reply is still awaited from ZR2 Bioenergy Ltd.
| |||||||||||||||
NSE admits further securities of 10 companies to dealings on the Capital Market segment effective April 15, 2026, including ESOP allotments … | |||||||||||||||
NSE admits further securities of 10 companies to dealings on the Capital Market segment effective April 15, 2026, including ESOP allotments and warrant conversions.
| |||||||||||||||
BSE announces securities shortlisted for Short Term ASM framework effective February 06, 2026, including 25 securities in Part A and … | |||||||||||||||
BSE announces securities shortlisted for Short Term ASM framework effective February 06, 2026, including 25 securities in Part A and movements between stages.
| |||||||||||||||
NSE admits additional securities from 15 companies including equity shares allotted under ESOP and preferential issues, effective September … | |||||||||||||||
NSE admits additional securities from 15 companies including equity shares allotted under ESOP and preferential issues, effective September 4, 2025.
| |||||||||||||||